Physician profile
Benjamin Goins
NPI 1144514753
$13,140.09
in general payments reported to CMS, 2019-2025
26 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.16 · 2020: $11.89 · 2022: $200 · 2023: $271 · 2024: $1,264 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $2,395 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,346.25 |
| Food and Beverage | $2,395.21 |
| Education | $105.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11,053.55 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $287.48 | 2022-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $250.62 | 2022-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $241.25 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $191.75 | 2024-2025 | Camzyos |
| Pfizer INC. | $154.86 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $147.56 | 2024 | Inpefa |
| Esperion Therapeutics, INC. | $107.29 | 2022-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.52 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $80.32 | 2023-2024 | Wainua |
| Janssen Pharmaceuticals, INC | $64.19 | 2024 | Xarelto |
| Cvrx, INC. | $61.80 | 2025 | Barostim Neo System |
| Boston Scientific Corporation | $52.76 | 2024 | Varithena Administration Pack, Watchman Flx |
| Bridgebio Pharma, INC. | $48.41 | 2025 | Attruby |
| Inspire Medical Systems, INC. | $42.64 | 2023-2025 | Inspire |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.13 | 2019 | |
| Vital Connect, INC | $34.82 | 2024 | Vitalpatch Rtm |
| Edwards Lifesciences Corporation | $30.41 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $29.49 | 2024-2025 | |
| Scpharmaceuticals INC. | $29.40 | 2025 | |
| Supernus Pharmaceuticals, INC. | $29.17 | 2019 | |
| Heartflow, INC. | $17.40 | 2023 | Ffrct |
| Medtronic, INC. | $14.52 | 2023 | Linq II |
| Bardy Diagnostics, INC. | $12.00 | 2022 | |
| Philips North America LLC | $11.89 | 2020 | |
| Zyla Life Sciences, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Goins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.